<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=cancer%26drug&amp;format=rss"><channel><title>cancer&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=cancer%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>cancer&amp;drug</title><link>http://www.bing.com/news/search?q=cancer%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.forbes.com%2fsites%2fjessepines%2f2026%2f04%2f14%2fnew-pancreatic-cancer-drug-nearly-doubles-survival-heres-what-patients-should-know%2f&amp;c=9314354108383661225&amp;mkt=en-us</link><description>Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.</description><pubDate>Tue, 14 Apr 2026 12:57:00 GMT</pubDate><News:Source>Forbes</News:Source><News:Image>http://www.bing.com/th?id=ONUT.M_-KXOSaZQGPNalM8Sbnzw&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>'I'm in remission for the first time due to new cancer drug'</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.aol.com%2fnews%2fim-remission-first-time-due-071039788.html&amp;c=17175871541591791008&amp;mkt=en-us</link><description>A woman whose multiple sclerosis masked the symptoms of an incurable blood cancer has outlived her prognosis of three to seven years and reached remission for the first time in almost a decade. Simone ...</description><pubDate>Sat, 18 Apr 2026 07:11:00 GMT</pubDate><News:Source>AOL</News:Source><News:Image>http://www.bing.com/th?id=ONUT.tWcBEBuMni9w1HbXsSdDig&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1104</News:ImageMaxWidth><News:ImageMaxHeight>621</News:ImageMaxHeight></item><item><title>New drug nearly doubles life expectancy for ‘notorious’ cancer — but ex-Sen. Ben Sasse highlights ‘nasty’ side effects</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fnypost.com%2f2026%2f04%2f15%2fhealth%2fnew-pancreatic-cancer-drug-nearly-doubles-life-expectancy%2f&amp;c=7223959111711302911&amp;mkt=en-us</link><description>A medical oncologist called the late-stage clinical trial results “remarkable,” though Sasse said the drug means his body “can’t grow skin and so I bleed all out of a whole bunch ...</description><pubDate>Wed, 15 Apr 2026 07:19:00 GMT</pubDate><News:Source>New York Post</News:Source><News:Image>http://www.bing.com/th?id=ONUT.DnhVtuV0vQ5S-reo9jlf2w&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>799</News:ImageMaxHeight></item><item><title>Experimental drug doubles one-year survival in pancreatic cancer</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fexperimental-drug-doubles-one-year-survival-in-pancreatic-cancer%2far-AA21cnP6&amp;c=59785433987072574&amp;mkt=en-us</link><description>A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.</description><pubDate>Sat, 18 Apr 2026 06:00:00 GMT</pubDate><News:Source>Live Science on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.UR1AWk4cK71E1sUCojIWsQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1280</News:ImageMaxWidth><News:ImageMaxHeight>720</News:ImageMaxHeight></item><item><title>Two New Drugs Offer Hope for Pancreatic Cancer</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2ftwo-new-drugs-offer-hope-for-pancreatic-cancer%2far-AA20S80o&amp;c=8669525587152839381&amp;mkt=en-us</link><description>New experimental medications seem to extend survival with the hard-to-treat cancer.</description><pubDate>Tue, 14 Apr 2026 09:26:00 GMT</pubDate><News:Source>TIME on MSN</News:Source><News:Image>http://www.bing.com/th?id=ORMS.27197dea708658911aa3968a8d677da4&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>3840</News:ImageMaxWidth><News:ImageMaxHeight>2160</News:ImageMaxHeight></item><item><title>Medicare Can Save $4 Billion On Four Cancer Drugs – Can You Guess Which Ones?</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.forbes.com%2fsites%2fpeterubel%2f2026%2f04%2f17%2fmedicare-can-save-4-billion-on-four-cancer-drugs--can-you-guess-which-ones%2f&amp;c=10384968532636653659&amp;mkt=en-us</link><description>That fourth drug is Pomalyst, a treatment from Bristol Myers Squibb for multiple myeloma. That’s a relatively uncommon cancer, but the drug costs about $150,000 per year for each patient. With a ...</description><pubDate>Fri, 17 Apr 2026 05:54:00 GMT</pubDate><News:Source>Forbes</News:Source><News:Image>http://www.bing.com/th?id=ONUT.zeSkg-OuHMuRgwz1BpJ4pA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1350</News:ImageMaxWidth><News:ImageMaxHeight>900</News:ImageMaxHeight></item><item><title>How Merck keeps prices for its blockbuster cancer drug sky high</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fhow-merck-keeps-prices-for-its-blockbuster-cancer-drug-sky-high%2far-AA20QzmU&amp;c=14609508028305908611&amp;mkt=en-us</link><description>Merck built a wall of patents that keeps a cancer drug's price – and its profits – high. Hospitals often add to the cost for American patients.</description><pubDate>Thu, 16 Apr 2026 16:23:48 GMT</pubDate><News:Source>USA TODAY on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.Q6GjA8_F4m-9H2UlllB2YQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>3000</News:ImageMaxWidth><News:ImageMaxHeight>1688</News:ImageMaxHeight></item><item><title>Why AI is becoming a powerful tool in cancer drug discovery</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.news-medical.net%2fnews%2f20260416%2fWhy-AI-is-becoming-a-powerful-tool-in-cancer-drug-discovery.aspx&amp;c=10617701396986846568&amp;mkt=en-us</link><description>This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important ...</description><pubDate>Thu, 16 Apr 2026 18:27:00 GMT</pubDate><News:Source>News-Medical.Net</News:Source><News:Image>http://www.bing.com/th?id=ONUT.h3hRje_z4SWbWKegr_tm6w&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>2000</News:ImageMaxWidth><News:ImageMaxHeight>1125</News:ImageMaxHeight></item><item><title>Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2frevolution-medicines-says-its-potential-breakthrough-pancreatic-cancer-drug-succeeds-in-late-stage-trial%2far-AA20LDfG&amp;c=10480857401486944367&amp;mkt=en-us</link><description>Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.</description><pubDate>Mon, 13 Apr 2026 07:38:00 GMT</pubDate><News:Source>CNBC on MSN</News:Source><News:Image>http://www.bing.com/th?id=ORMS.7d42be3111406c05d3c0c7046b81c81e&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1920</News:ImageMaxWidth><News:ImageMaxHeight>1080</News:ImageMaxHeight></item><item><title>Pancreatic cancer pill shown to nearly double overall survival time, drug company says</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2fpancreatic-cancer-pill-shown-nearly-115349180.html&amp;c=18082897859664840659&amp;mkt=en-us</link><description>A pancreatic cancer drug is showing promising signs of a possible breakthrough after a clinical trial found it nearly doubled the length of survival among patients. In a press release Monday, ...</description><pubDate>Tue, 14 Apr 2026 07:15:00 GMT</pubDate><News:Source>Yahoo</News:Source><News:Image>http://www.bing.com/th?id=ONUT.jdImOBAyTYzmQm4A34F49A&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>900</News:ImageMaxWidth><News:ImageMaxHeight>505</News:ImageMaxHeight></item><item><title>US judge rejects Bayer bid to block Johnson &amp; Johnson prostate cancer drug claims</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fus-judge-rejects-bayer-bid-to-block-johnson-johnson-prostate-cancer-drug-claims%2far-AA21apw8&amp;c=16618472309589448311&amp;mkt=en-us</link><description>By Jonathan Stempel NEW YORK, April 17 (Reuters) - A U.S. judge has rejected Bayer's request for an injunction to block Johnson &amp; Johnson's alleged false advertising that its multibillion-dollar drug ...</description><pubDate>Fri, 17 Apr 2026 19:36:11 GMT</pubDate><News:Source>Reuters on MSN</News:Source><News:Image>http://www.bing.com/th?id=ORMS.537824bc316b54bfb04ff19774886886&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1920</News:ImageMaxWidth><News:ImageMaxHeight>1005</News:ImageMaxHeight></item><item><title>The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e3e53f2f43497aaadd1e2fa8c8acf1&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2fblockbuster-cancer-drug-keytruda-cost-133604305.html&amp;c=6411890297183154215&amp;mkt=en-us</link><description>Merck &amp; Co.'s Keytruda in the U.S. starts at $12,000 for a 200 mg dose. Costs go up from there based on the insurer, provider and middlemen involved.</description><pubDate>Wed, 15 Apr 2026 07:37:00 GMT</pubDate><News:Source>Yahoo</News:Source><News:Image>http://www.bing.com/th?id=ONUT.__tKqzlxBoMo0q6aXrI2Eg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1200</News:ImageMaxWidth><News:ImageMaxHeight>800</News:ImageMaxHeight></item></channel></rss>